Press release
2025-2034 Diffuse Large B-cell Lymphoma Therapeutics Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights
Diffuse Large B-cell Lymphoma Therapeutics
What Will the Diffuse Large B-cell Lymphoma Therapeutics Industry Market Size Be by 2025?
The market size for therapeutics in diffuse large b-cell lymphoma has seen a substantial increase in the past few years. It is projected to rise from $4.74 billion in 2024 to $5.1 billion in 2025, with a compound annual growth rate (CAGR) of 7.5%. Advances in clinical research, regulatory approvals, increased patient awareness and diagnosis, collaborative efforts, and evolution of care standards are all contributing factors to the growth witnessed in the historic period.
What's the Long-Term Growth Forecast for the Diffuse Large B-cell Lymphoma Therapeutics Market Size Through 2029?
In the coming years, the diffuse large b-cell lymphoma therapeutics market is predicted to experience considerable growth, expanding to "$6.92 billion in 2029 with a compound annual growth rate (CAGR) of 7.9%. The growth in this forecasted period can be credited to factors like advancements in immunotherapy, high rates of disease incidence, an aging global population, improved healthcare infrastructure, and greater access to innovative drugs. The leading trends anticipated in this period are the growth of outpatient treatment environments, cooperative clinical studies, patient-centric care frameworks, advancements in diagnostic imaging technology, and the digitalization of the healthcare sector.
View the full report here:
https://www.thebusinessresearchcompany.com/report/diffuse-large-b-cell-lymphoma-therapeutics-global-market-report
What Are the Key Growth Drivers Fueling the Diffuse Large B-cell Lymphoma Therapeutics Market Expansion?
The rise in occurrences of diffuse large B-cell lymphoma (DLBCL) has the potential to fuel the expansion of the DLBCL therapeutics market. As an aggressive cancer type that starts in the B-cells of the lymphatic system, DLBCL, a form of non-Hodgkin lymphoma (NHL), is notorious for its swift and uncontrolled growth. DLBCL therapeutics are beneficial in enhancing the prognosis for those suffering from the disease by specifically targeting and managing the cancer cells. The American Cancer Society, a voluntary health organization from the US, anticipates that approximately 80,550 individuals (44,880 men and 35,670 women) will be diagnosed with NHL in 2023, and around 20,180 fatalities will transpire as a result of NHL. Accordingly, the escalating prevalence of DLBCL is instrumental in driving the growth of the DLBCL therapeutics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10805&type=smp
What Are the Key Trends Driving Diffuse Large B-cell Lymphoma Therapeutics Market Growth?
The projection of development drug therapies is emerging as a prominent trend in the diffuse large B-cell lymphoma therapeutics market. Major market players, as part of their strategic initiatives, are producing drugs for these therapies to maintain their market dominance. For instance, in June 2022, Bristol-Myers Squibb, a leading pharmaceutical entity from the US, focusing on R&D of drugs, garnered US FDA approval for its Breyanzi, a CAR T Cell Therapy for patients with diffuse large B-cell lymphoma (DLBCL), large B-cell lymphoma (LBCL), and recurrent or resistant large B-cell lymphoma. Breyanzi, a CD19-focused chimeric antigen receptor (CAR) T-cell therapy, caters to a diverse demographic of patients suffering from primary mediastinal large B-cell lymphoma, high-grade B-cell lymphoma, and follicular lymphoma grade 3B.
How Is the Diffuse Large B-cell Lymphoma Therapeutics Market Segmented?
The diffuse large b-cell lymphoma therapeutics market covered in this report is segmented -
1) By Drug Class: Cisplatin, Carboplatin, 5-fluorouracil, Docetaxel, Paclitaxel, Methotrexate, Other Drugs
2) By Therapy: Targeted Therapy, Immunotherapy, Chemotherapy, Other Therapies
3) By Route of Administration: Oral, Parenteral, Other Routes
4) By End User: Hospitals, Clinics, Other End-Users
Subsegments:
1) By Cisplatin: Injection Formulations, Combination Therapies
2) By Carboplatin: Injection Formulations, Combination Therapies
3) By 5-Fluorouracil: Injection Formulations, Oral Formulations
4) By Docetaxel: Injection Formulations, Combination Therapies
5) By Paclitaxel: Injection Formulations, Combination Therapies
6) By Methotrexate: Injection Formulations, Oral Formulations, Combination Therapies
7) By Other Drugs: Monoclonal Antibodies, Targeted Therapies, Immunotherapies, Experimental Therapies
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10805&type=smp
Which Companies Are Leading the Charge in Diffuse Large B-cell Lymphoma Therapeutics Market Innovation?
Major companies operating in the diffuse large B-cell lymphoma therapeutics market include Novartis AG, Pfizer Inc., Merck & Co Inc., GlaxoSmithKline plc, F. Hoffmann-La Roche AG, CTI BioPharma Corp., Celltrion Healthcare Co Ltd., Bristol-Myers Squibb Company, AbbVie Inc., Gilead Sciences Inc., Seagen Inc., Kite Pharma Inc., ADC Therapeutics SA, Bayer AG, Xencor Inc., Autolus Therapeutics plc, Allogene Therapeutics Inc., Spectrum Pharmaceuticals Inc., AstraZeneca PLC, Aptevo Therapeutics Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson, Celgene Corporation, Eli Lilly and Company, Sanofi SA, Seattle Genetics Inc., Karyopharm Therapeutics Inc., TG Therapeutics Inc., MorphoSys AG
Which Regions Are Leading the Global Diffuse Large B-cell Lymphoma Therapeutics Market in Revenue?
North America was the largest region in the global diffuse large B-cell lymphoma therapeutics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diffuse large B-cell lymphoma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10805
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2025-2034 Diffuse Large B-cell Lymphoma Therapeutics Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights here
News-ID: 4180593 • Views: …
More Releases from The Business Research Company
Top Market Shifts Transforming the Gastroesophageal Reflux Disease Therapeutics …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Gastroesophageal Reflux Disease Therapeutics Market Through 2025?
The market size of therapeutics for gastroesophageal reflux disease has seen a consistent progression in the past few years. This market is forecasted to expand from $5.93 billion in 2024 to $6.08 billion in 2025,…
Retinal Disorder Treatment: Core Growth Enabler in the Rising Incidence Of Retin …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Retinal Disorder Treatment Industry Market Size Be by 2025?
In past years, the retinal disorder treatment market has witnessed significant growth. The market worth which stood at $12.59 billion in 2024, is expected to surge to $13.69 billion in 2025, approximating a compound annual growth rate…
Enzyme Replacement Therapy Market Set To Surge Due To Escalating Prevalence Of C …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Enzyme Replacement Therapy Market Size Growth Forecast: What to Expect by 2025?
In the recent past, there has been substantial growth in the market size of enzyme replacement therapy. The market value is projected to rise from $11.58 billion in 2024 to $12.36 billion in 2025, reflecting a compound…
Proton Pump Inhibitors Market Expansion Continues, with Forecast Valuation of $4 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Proton Pump Inhibitors Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for proton pump inhibitors has been on a consistent growth trajectory in the recent past. It is anticipated to surge from $3.4 billion in 2024 to $3.51 billion in 2025, indicating…
More Releases for Therapeutics
Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years.
DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr
Some of the…
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years.
DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,…
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611
Focused on growth…
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan.
Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Hodgkin's…
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space.
Key Takeaways from…
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
